Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

Home > What's New > Past Science Meetings    

Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Addiction Treatment



Speaker Biographies


Ira J. Marion, M.A.
Executive Director
Division of Substance Abuse
Albert Einstein College of Medicine
1500 Waters Place
Bronx, NY 10461
(718) 409-9450, ext. 312
(718) 892-7115 Fax
noiramarion@email.msn.com

Mr. Marion is Executive Director of the Division of Substance Abuse at Albert Einstein College of Medicine, Yeshiva University, and the Substance Abuse Treatment Program at Montefiore Medical Center. He has been at Einstein since 1970 and has held executive-level positions in the division since 1977. Einstein's Division of Substance Abuse is New York State's second largest drug treatment provider. Mr. Marion earned a master's degree from the City University of New York and pursued doctoral studies in public health at Columbia University. Throughout his career, Mr. Marion has provided consultation and active leadership in many professional organizations and on several advisory boards and committees. He is a member of the New York State Governor's Substance Abuse Advisory Council and is Past President and member of the Executive Board of the New York State Association of Alcoholism and Substance Abuse Providers and other coalitions. Mr. Marion has spoken at, planned, and chaired many substance abuse conferences, including statewide and national meetings; is the author of several articles and book chapters; and has chaired Center for Substance Abuse Treatment Treatment Improvement Protocols.

<< Back


Francis A. McCorry, Ph.D.
Director
Clinical Services Unit
New York State Office of Alcoholism and Substance Abuse Services
501 Seventh Avenue
New York, NY 10018-5903
(646) 728-4690
(646) 728-4690 Fax
frankmccorry@oasas.state.ny.us

Dr. McCorry is Director of the Clinical Services Unit of the New York State Office of Alcoholism and Substance Abuse Services (OASAS). He is responsible for clinical practice issues, particularly in the areas of public health, co-occurring mental health and addictive disorders, and managed care. Dr. McCorry represents OASAS on a joint initiative with the Office of Mental Health on co-occurring disorders, which developed the "New York Model," a conceptual paradigm for the treatment of persons with co-occurring disorders. This paradigm has been endorsed by the Substance Abuse and Mental Health Services Administration (SAMHSA), National Association of State Alcohol and Drug Abuse Directors, and National Association of State Mental Health Program Directors. Dr. McCorry also oversees the development of new initiatives that respond to emerging issues, such as improving clinical practice through evidence-based interventions and hepatitis prevention and control. He was Principal Investigator of a SAMHSA cooperative agreement to study the effects of Medicaid managed care on alcohol and other drug services and Co-Principal Investigator of a similar study involving adolescents. Dr. McCorry is also Principal Investigator of the New York Practice Research Collaborative, a Center for Substance Abuse Treatment (CSAT) cooperative agreement to improve clinical practice through the use of evidence-based practice and develop a clinically driven research agenda. He is Project Director of a CSAT planning grant to identify barriers to a more seamless service system for persons with HIV infection and substance abuse treatment needs. Dr. McCorry is Chair of the Washington Circle Group, a CSAT-sponsored national organization to develop substance abuse performance measures for use in managed care settings. He is also Editor of the Group's recently released report Improving Performance Measures for Alcohol and Other Drug Services (March 2000). Dr. McCorry is also a faculty member at the Nathan Kline Institute's Center for the Study of Issues in Public Mental Health.

<< Back


David McDowell, M.D.
Medical Director
New York State Psychiatric Institute
Columbia University
STARS-Basement
600 West 168th Street
New York, NY 10032
(212) 543-4994
(212) 923-4372 Fax
dmm6@columbia.edu

View Presentation [PDF format, 1MB]


Kevin McEneaney
Executive Vice President and Chief Operating Officer
Phoenix House Foundation, Inc.
164 West 74th Street
New York, NY 10023
(212) 595-5810, ext. 7200
(212) 721-2164 Fax
kmac@phoenixhouse.org

Mr. McEneaney took charge of clinical programming for Phoenix House as Senior Vice President and Director of Clinical Services in 1983. He became Chief Operating Officer in 1995 and was named Executive Vice President the following year. Mr. McEneaney is a key leader in the drug abuse treatment field and since 1998 has served as President of Therapeutic Communities of America (TCA), an organization representing 60 treatment agencies and more than 500 programs in the United States and Canada. Mr. McEneaney was an early graduate of Phoenix House and earned a bachelor's degree from Fordham University in New York and a certificate in public relations management from New York University. In 1993 he took part in the "Achieving Breakthrough Service" program of the Harvard Business School's Executive Education Program. For Phoenix House, Mr. McEneaney developed a pilot community drug abuse clinic in Boston, working with Tufts University and the New England Medical Center. While Director of Public Relations for Phoenix House from 1972 to 1983, he developed the Phoenix House Drug Education and Prevention Program, which reached more than 40,000 students and several thousand parents in private and public schools throughout the country. An outgrowth of this prevention program was IMPACT, the Phoenix House drug intervention program for drug-troubled teenagers and their parents. In 1990 Mr. McEneaney was instrumental in bringing Phoenix House treatment programs to New York State's Marcy Correctional Facility and the Taconic Correctional Facility for women in Bedford. At the World Federation of Therapeutic Communities Year 2000 Conference, he was honored for his leadership in the treatment field.

View Presentation [PDF format, 136K]

<< Back


Paul McLaughlin, M.A.
Executive Director
Hartford Dispensary
345 Main Street
Hartford, CT 06106
(860) 525-2181
(860) 525-7332 Fax
hsisp@worldnet.att.net

Mr. McLaughlin began his managerial career in the field of outpatient methadone treatment in 1971 as Administrator of the Narcotic Treatment Program at the Stamford, Connecticut, Health Department. In 1977 he became Associate Director of the Drug Dependence Unit in the Department of Psychiatry at Yale University, where he developed an appreciation for the role of research in the development of evidence-based clinical practices and treatment models. This experience influenced his belief that research in a community setting is both feasible and appropriate. For the past 22 years Mr. McLaughlin has served as Executive Director of the Hartford Dispensary, a community-based organization that operates six accredited outpatient methadone treatment programs serving approximately 3,100 patients per day. He is also Chair of the Connecticut Methadone Treatment Directors, Founding Director of the American Association for the Treatment of Opioid Dependence, and a representative of the New England Node of NIDA's Clinical Trials Network's National Steering Committee.

View Presentation [PDF format, 96K]

<< Back


Laura F. McNicholas, M.D., Ph.D.
Director
Center of Excellence in Substance Abuse Treatment and Education
Philadelphia Veterans Affairs Medical Center
University of Pennsylvania School of Medicine
Mail Symbol 116-East
University and Woodland Avenues
Philadelphia, PA 19104
(215) 823-6085
(215) 823-4690 Fax
mcnicholas_l@mail.trc.upenn.edu

Dr. McNicholas received her Ph.D. degree in pharmacology from the University of Kentucky, where she conducted research on the animal pharmacology of drugs of abuse. She completed medical school at the University of Kentucky and a psychiatry residency and fellowship in clinical research in substance abuse at the University of Pennsylvania School of Medicine. Dr. McNicholas joined the faculty of the Department of Psychiatry at the University of Pennsylvania and the medical staff at the Methadone Maintenance Program at the Philadelphia Veterans Affairs Medical Center (VAMC) in 1992. She is Director of the Center of Excellence in Substance Abuse Treatment and Education at the Philadelphia VAMC. Dr. McNicholas also serves as Consultant to the Drug Abuse Advisory Committee of the Food and Drug Administration and to the Federation of State Medical Boards. Her research interests include new pharmacotherapeutic approaches to the treatment of opioid dependence and the treatment of benzodiazepine dependence. Dr. McNicholas has participated in multicenter clinical trials of buprenorphine in the treatment of opioid dependence and chairs the Center for Substance Abuse Treatment's Consensus Panel on Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Dependence.

View Presentation [PDF format, 380K]

<< Back


Gloria M. Miele, Ph.D.
Program Director
Women's Health Project Treatment and Research Center
Columbia University
St. Luke's-Roosevelt Hospital Center
Suite 3B
411 West 114th Street
New York, NY 10025
(212) 523-7722
(212) 523-2140 Fax
gmm23@columbia.edu

Dr. Miele is a clinical psychologist who for many years has been blending research and practice in assessing and treating individuals with substance use and comorbid mental disorders. She is Program Director of the Women's Health Project (WHP) Treatment and Research Center, St. Luke's-Roosevelt Hospital Center in New York City. The WHP focuses on developing, testing, and providing specific treatments for women with histories of trauma who also struggle with addictions. She is also Research Scientist at the New York State Psychiatric Institute, where she is Training Coordinator of the Long Island Regional Node of NIDA's Clinical Trials Network. Dr. Miele is on the faculty of the Columbia University College of Physicians and Surgeons and provides clinical supervision for psychology trainees. She also has a private practice in New York City.

<< Back


Laurie S. Miller, Ph.D.
Associate Professor of Psychiatry
New York University Child Study Center
New York University School of Medicine
577 First Avenue
New York, NY 10016
(212) 263-8673
(212) 263-8662 Fax
laurie.miller.2@med.nyu.edu

Dr. Miller is Associate Professor of Psychiatry at the New York University (NYU) School of Medicine and Director of the Institute for Children at Risk at the NYU Child Study Center. She is a clinical developmental psychologist with clinical and research expertise in the development, prevention, and treatment of early childhood conduct problems. Dr. Miller is also Principal Investigator of two federally funded intervention trials aimed at preventing conduct problems among children from poor, urban neighborhoods by enhancing parenting competencies and community building. She is interested in translating and disseminating scientifically based information on parenting and children's mental health in an effort to prevent conduct problems and youth violence.

View Presentation [PDF format, 272K]

<< Back


Dennis C. Moore, Ed.D.
Associate Professor
Community Health Director
Substance Abuse Resources and Disability Issues
Wright State University School of Medicine
P.O. Box 927
Dayton, OH 45401-0927
(937) 775-1484
(937) 775-1495 Fax
dennis.moore@wright.edu

Dr. Moore is Associate Professor in the Department of Community Health at the Wright State University School of Medicine. He directs the Rehabilitation Research and Training Center on Drugs and Disability and the Substance Abuse Resources and Disability Issues program. Dr. Moore is the originator of the Consumer Advocacy Model program, a substance use disorder treatment program in Dayton for persons with severe, coexisting disabilities. He holds advanced degrees in counseling and special education and clinical licenses in counseling and substance dependence treatment. Dr. Moore has published several articles in areas relating to substance abuse and disability epidemiology, treatment, and policy.

View Presentation [PDF format, 176K]

<< Back


Ellen Morehouse, M.S.W., CASAC
Executive Director
Student Assistance Services Corporation
660 White Plains Road
Tarrytown, NY 10591
(914) 332-1300
cbelles@sascorp.org

Ms. Morehouse is Executive Director of Student Assistance Services Corporation, a nonprofit substance abuse prevention agency in Tarrytown, New York. She has created and implemented science-based prevention programs in middle schools, high schools, alternative schools, residential child care facilities, and colleges through grants from the Center for Substance Abuse Prevention, National Institute on Alcohol Abuse and Alcoholism, Centers for Disease Control and Prevention, U.S. Department of Education, and New York State Office of Alcoholism and Substance Abuse Services.

<< Back


Jon Morgenstern, Ph.D.
Vice President and Director of Health and Treatment Research and Analysis
National Center on Addiction and Substance Abuse at Columbia University
633 Third Avenue
New York, NY 10017-6706
(212) 841-5247
(212) 956-8020 Fax
jmorgens@casacolumbia.org

Dr. Morgenstern is Director of Treatment Research at the National Center on Addiction and Substance Abuse at Columbia University. He is also Associate Professor of Psychiatry and Health Policy and Director of Alcohol Treatment and Research Programs at the Mount Sinai School of Medicine. Dr. Morgenstern received his doctorate in clinical psychology from New York University and completed postdoctoral training at the Center of Alcohol Studies at Rutgers University. His research interests include testing the efficacy of behavioral interventions for substance use disorders and transferring knowledge from research to practice. Dr. Morgenstern is studying the efficacy of using motivational interviewing to treat the co-occurence of problem drinking and HIV risk behaviors.

View Presentation [PDF fromat, 164K]

<< Back


Andrew R. Morral, Ph.D.
Associate Director
Criminal Justice Program
RAND Corporation
1200 South Hays Street
Arlington, VA 22202-5050
(703) 413-1100
(703) 413-8111 Fax
andrew_morral@rand.org

Dr. Morral is Associate Director of RAND's Criminal Justice Program and Behavioral Scientist in RAND's Drug Policy Research Center. His research interests include adolescent substance abuse and substance abuse treatments in criminal justice settings. Dr. Morral has worked closely with criminal justice agencies and community treatment providers to develop program evaluation strategies and treatment planning instruments.

View Presentation [PDF format, 112K]

<< Back


Madeline A. Naegle, R.N., Ph.D., CS, FAAN
Associate Professor
Division of Nursing
New York University
246 Greene Street
New York, NY 10003-6677
(212) 998-5321
(212) 995-4679 Fax
madeline.naegle@nyu.edu

Dr. Naegle is Associate Professor at New York University's Division of Nursing. She coordinates the Advanced Practice: Psychiatric-Mental Health Nursing Program and the Division's Office of International Affairs. In addition to preparing nurses for mental health and addictions practice, Dr. Naegle has edited a book and a model curriculum for substance abuse education in nursing and has published numerous journal articles on the clinical aspects of addiction care. She has served as the American Nurses Association spokesperson on impairment of professional practice, and she is an author, editor, and consultant on policy statements and practice guidelines for addictions nursing. Dr. Naegle practices part time as a nurse-psychotherapist specializing in the treatment of substance-related disorders.

<< Back


Lisa Najavits, Ph.D.
Director
Trauma Research Program and Alcohol and Drug Abuse Program
Associate Professor of Psychology
McLean Hospital
Harvard Medical School
115 Mill Street
Belmont, MA 02478
(617) 855-2305
(617) 855-3605 Fax

Dr. Najavits is Associate Professor in the Department of Psychiatry at Harvard Medical School and Director of the Trauma Research Program, Alcohol and Drug Abuse Treatment Center, at McLean Hospital in Belmont, Massachusetts. She is the author of Seeking Safety: Cognitive-Behavioral Therapy for PTSD and Substance Abuse (Guilford Press, 2002). Dr. Najavits received the 1997 Chaim Danieli Young Professional Award of the International Society for Traumatic Stress Studies and the 1998 Early Career Contribution Award of the Society for Psychotherapy Research. She also has received four National Institutes of Health grants, including an Independent Scientist Award. Dr. Najavits is a practicing therapist and psychotherapy supervisor.

<< Back


Edward V. Nunes, M.D.
Director
Long Island Node, NIDA Clinical Trials Network
Associate Professor of Clinical Psychiatry
College of Physicians and Surgeons
Columbia University
Unit 51
1051 Riverside Drive
New York, NY 10032
(212) 543-5581
(212) 543-5326 Fax
nunesed@pi.cpmc.columbia.edu

Dr. Nunes is Associate Professor of Clinical Psychiatry at Columbia University and Research Psychiatrist at the New York State Psychiatric Institute, where he directs a variety of research projects on the treatment of opiate, cocaine, and alcohol dependence. He completed medical school at the University of Connecticut and his residency and fellowship training at Columbia University. Areas of special interest include the identification and treatment of co-occurring depression and other psychiatric disorders among patients in treatment for substance abuse, the development of combined pharmacologic and behavioral interventions, and the design of research in community-based treatment settings.

<< Back


Alice Ostrowsky, M.A.
Vocational Director
Substance Abuse Programs
The Educational Alliance, Inc.
371 East 10th Street
New York, NY 10009
(212) 533-2470, ext. 223
(212) 673-9346 Fax
alice_ostrowsky@edalliance.org

Ms. Ostrowsky is Vocational Director of Substance Abuse Programs at The Educational Alliance, Inc., a settlement house, community center, and social service agency with more than 100 years of experience serving the Lower East Side of New York City. The social service division includes three substance abuse treatment programs. Clients in these programs are offered a comprehensive array of vocational services designed to help them achieve the goal of self-support through competitive employment. Ms. Ostrowsky is a certified rehabilitation counselor with a master's degree in vocational rehabilitation counseling from New York University. She has more than 10 years of combined experience providing rehabilitation services to people with alcohol and substance abuse problems and people with mental illness. Ms. Ostrowsky has provided training to staff members and students who serve recovering substance abusers to assist them in understanding the goals and process of vocational rehabilitation and identifying and overcoming obstacles to successful outcomes.

<< Back


Eileen Pencer, M.S.W., M.Ed., CSW, ACSW
President and CEO
Lower Eastside Service Center, Inc.
Eighth Floor
157 Chambers Street
New York, NY 10007
(917) 576-6186
(212) 732-5224 Fax
epencer@lesc.org

Ms. Pencer is President and CEO of Lower Eastside Service Center, Inc. (LESC), a multiservice agency providing outpatient and residential core substance abuse treatment services in addition to mental health, vocational, HIV/TB/hepatitis education and screening, primary medical care, and psychiatric services. LESC's commitment to meet the evolving needs of its clients has led to numerous new programming initiatives focusing on family preservation, criminal justice, and moving clients from welfare to work. LESC is committed to being an active participant in the substance abuse treatment community. In this regard, Ms. Pencer was recently elected President of the Alcoholism and Substance Abuse Providers of New York State. In the area of treatment research, LESC is an active member of NIDA's Clinical Trials Network (CTN), and Ms. Pencer serves on the CTN National Steering Committee. Two research studies, Motivational Interviewing and Motivational Incentives, are currently under way in LESC's clinics. LESC staff members have found that their participation in these protocols has enriched their work experience and increased their curiosity about potential best practices being studied elsewhere in the CTN.

<< Back


Kenneth Perez, M.S.
Upstate Coordinator
Vocational Rehabilitation and Employment Services
New York State Office of Alcoholism and Substance Abuse Services
1450 Western Avenue
Albany, NY 12203
(518) 485-2156
(518) 402-2847 Fax
lenperez@oasas.state.ny.us

Mr. Perez is Upstate Coordinator of Vocational Rehabilitation and Employment Services for the New York State (NYS) Office of Alcoholism and Substance Abuse Services (OASAS). He is responsible for the integration of the full range of vocational services in OASAS-licensed alcohol and substance abuse treatment programs within a region comprising the 55 counties north of New York City. Mr. Perez also serves as the agency lead on policy- and program-related issues pertaining to persons with coexisting disabilities. His tenure with OASAS began in 1989 as director of a 3-year project to improve the quality and accessibility of alcohol and substance abuse treatment services for individuals with cognitive disabilities. During this period, Mr. Perez developed a comprehensive cross-training curriculum on alcohol and substance abuse and cognitive disabilities and served as Compliance Coordinator for the Americans with Disabilities Act (ADA). He coordinates a research project supported by OASAS and the Mount Sinai Medical Center that is studying clients in alcohol and substance abuse treatment programs to determine the prevalence and etiology of coexisting traumatic brain injuries. Prior to entering NYS service in 1986, Mr. Perez worked for 15 years in the field of rehabilitation as a counselor and program administrator. He received his M.S. degree in rehabilitation counseling from the State University of New York, Albany.

<< Back


Beny J. Primm, M.D.
Executive Director
Addiction Research and Treatment Corporation
22 Chapel Street
Brookly, NY 11201
(718) 260-2950
(718) 260-9492 Fax
bprimm@artcny.org

<< Back


Richard Rawson, Ph.D.
Associate Director
Integrated Substance Abuse Programs
University of California, Los Angeles
Suite 100
11050 Santa Monica Boulevard
Los Angeles, CA 90025
(310) 312-0500, ext. 511
matrixex@ucla.edu

Dr. Rawson is the Associate Director of the University of California, Los Angeles, Integrated Substance Abuse Programs, UCLA Department of Psychiatry. For the past 25 years, Dr. Rawson has conducted extensive research in the substance abuse field. A principal investigator on numerous CSAT and NIDA-funded research projects, he has chaired various grant reviews and technical review panels. In addition to his many consulting and research positions, Dr. Rawson has provided national and international training to public and private substance abuse funding and treatment agencies. Dr. Rawson has more than 100 published articles and book chapters.

View Presentation [PDF format, 504K]

<< Back


Malcolm S. Reid, Ph.D.
Assistant Professor
Department of Psychiatry
Department of Veterans Affairs
New York University School of Medicine
Room 116A
423 East 23rd Street
New York, NY 10010
(212) 686-7500, ext. 7983
(212) 951-6891 Fax
malcolm.reid@med.va.gov

Dr. Reid was Co-Investigator in the New York University/NIDA/Veterans Affairs (VA) Medications Development Research Unit (MDRU) and Director of three MDRU clinical trials investigating several medication treatments (e.g., valproate, olanzapine, coenzyme Q10/L-carnitine, Celebrex, mecamylamine) for cocaine dependence. He completed a research fellowship in substance abuse treatment research directed by Drs. Sharon Hall and Paul Berger at the University of California, San Francisco. Dr. Reid has a doctoral degree in pharmacology from the Karolinska Institute, Stockholm, Sweden, and more than 15 years of experience in substance abuse research. He is Co-Principal Investigator of the New York Node of NIDA's Clinical Trials Network (CTN). He is also Principal Investigator of a multisite CTN trial of buprenorphine/naloxone treatment for opiate detoxification and Lead Investigator of a multisite CTN smoking cessation study. Dr. Reid is Chairman of the New York VA Medical Center Research and Development Committee. He has several years of experience studying cue-induced alcohol and other drug craving and has completed numerous medication screening tests and a recent investigation of brain activation using quantitative EEG neuroimaging techniques. Dr. Reid's cue-induced craving laboratory is currently examining QEEG activation during cue-induced cocaine and alcohol craving.

View Presentation [PDF format, 480K]

<< Back


Paula Riggs, M.D.
Principal Investigator
Rocky Mountain Node, NIDA Clinical Trials Network
Associate Professor of Psychiatry
Director of Psychiatric Services for Adolescents
Addiction Research and Treatment Services
University of Colorado Health Sciences Center

Dr. Riggs is Associate Professor of Psychiatry and the Director of Psychiatric Services for Adolescents of Addiction Research and Treatment Services at the University of Colorado Health Sciences Center. She is certified in adult, child, and adolescent psychiatry by the American Board of Neurology and Psychiatry, with added qualifications in addiction psychiatry. Dr. Riggs is internationally known for her research and clinical expertise in the assessment and integrated treatment of comorbid disorders in adolescents with substance use disorders. She is Principal Investigator of the NIDA Clinical Trials Network, Rocky Mountain Node, as well as Principal Investigator of a 5-year NIDA treatment research grant investigating the differential efficacy of cognitive behavioral therapy and pharmacotherapy for depression in substance-dependent adolescents.

View Presentation 1 [PDF format, 208K]
View Presentation 2 [PDF format, 64K]

<< Back


Mitchell S. Rosenthal, M.D.
President
Phoenix House Foundation, Inc.
164 West 74th Street
New York, NY 10023
(212) 595-5810, ext. 7100
(212) 787-5295 Fax
mrosenthal@phoenixhouse.org

Dr. Rosenthal is a psychiatrist and President of the Phoenix House Foundation, Inc. He is a pioneer in substance abuse treatment who began work in the field in 1965 and has served as a White House advisor on drug policy, Special Consultant to the White House Office of National Drug Control Policy, and Chair of the New York State Advisory Council on Substance Abuse from 1985 to 1997. Dr. Rosenthal is Lecturer in Psychiatry at Columbia University's College of Physicians and Surgeons. As a U.S. Navy psychiatrist, he established the first service-connected therapeutic community and subsequently founded Phoenix House in 1967 when he was Deputy Commissioner of New York City's Addiction Services Agency. Since resigning his city post in 1970, Dr. Rosenthal has built Phoenix House into the Nation's largest nonprofit substance abuse services system, with more than 90 programs in 8 States (New York, California, Florida, Texas, Massachusetts, New Hampshire, Rhode Island, and Vermont). Its activities include residential and outpatient treatment for more than 5,500 adults and adolescents; residential high schools that integrate education and treatment; classroom and workplace prevention programs; treatment units serving clients in the criminal justice system and homeless shelters; research; training; and the preparation and distribution of prevention publications and other materials.

<< Back


Richard N. Rosenthal, M.D.
Chairman
Department of Psychiatry
St. Luke's-Roosevelt Hospital Center
16th Floor
1090 Amsterdam Avenue
New York, NY 10025
(212) 523-5366
(212) 523-3477 Fax
rosenthal@slrhc.org

Dr. Rosenthal is Chairman of the Department of Psychiatry at St. Luke's-Roosevelt Hospital Center and Professor of Clinical Psychiatry (pending) at the Columbia University College of Physicians and Surgeons. Since 1984 at Beth Israel Medical Center, where he was Unit Chief of one of the first addiction psychiatry inpatient services in the United States, he has acquired extensive research, clinical, and administrative experience in the integration of mental health and addiction services. Dr. Rosenthal is also a clinical and program development consultant to hospitals and State and Federal agencies. He is President of the American Academy of Addiction Psychiatry and a fellow of both the American Psychiatric Association and the New York Academy of Medicine. Dr. Rosenthal also serves on the Committee on Certification in Addiction Psychiatry of the American Board of Psychiatry and Neurology. He graduated from Oberlin College and received his master's degree in physiology and pharmacology at Duke University and his M.D. degree at the State University of New York, Downstate.

View Presentation [PDF format, 508K]

<< Back


Jami Rothenberg, Ph.D.
Assistant Clinical Professor of Medical Psychology
Columbia University
Research Scientist and Director
Division on Substance Use
Substance Treatment and Research Services (STARS)
New York State Psychiatric Institute
Unit 120
1051 Riverside Drive
New York, NY 10032
(212) 543-2456
(212) 923-4372 Fax
rothenb@pi.cpmc.columbia.edu

Dr. Rothenberg is Assistant Clinical Professor of Medical Psychology at Columbia University and Research Scientist at the New York State Psychiatric Institute. In addition, as Director of the Substance Treatment and Research Services (STARS) in the Division on Substance Use, she supervises the training and delivery of psychotherapy for participants in treatment research programs. Dr. Rothenberg graduated from the Medical College of Pennsylvania and Hahnemann University with a doctorate in clinical psychology. She is a New York State-licensed psychologist in private practice and has been conducting clinical and research work in the areas of health psychology, substance use, HIV risk behavior, and personality disorders for the past 6 years. Recently, Dr. Rothenberg collaborated on the development of a behavioral therapy treatment manual for heroin abusers and a cognitive-behavioral manual to address motivation and behavior change in substance users engaging in HIV-risk behavior.

View Presentation [PDF format, 408K]

<< Back


John Rotrosen, M.D.
Director
New York Node, NIDA Clinical Trials Network
Professor
Department of Psychiatry
New York University School of Medicine
423 East 23rd Street
New York, NY 10010
(212) 263-6802
(212) 951-6891 Fax
john.rotrosen@med.nyu.edu

Dr. Rotrosen is Professor of Psychiatry at the New York University (NYU) School of Medicine. His work focuses on the neurobiology and psychopharmacology of schizophrenia and chemical dependency. Dr. Rotrosen attended the NYU School of Medicine from 1968 to 1972 and completed his psychiatric training at NYU and Bellevue Hospital in 1976. His research training was supported in part by a National Institute of Mental Health (NIMH) Research Scientist Career Development Award under the mentorship of Drs. Samuel Gershon and Burt Angrist. Dr. Rotrosen served as Chief of the Psychiatry Service at the New York Veterans Affairs Medical Center from 1980 through 1997 and is now Associate Chief of Staff for Mental Health Research there. He and his collaborators' research includes studies on (1) the pathophysiology of schizophrenia; (2) therapeutic actions and acute and long-term side effects of antipsychotic drugs; (3) brain structure, function, and chemistry in schizophrenia and addictive disorders using positron emission tomography and magnetic resonance neuroimaging methodology; (4) development of therapeutics for opiate and cocaine addiction; and (5) development of therapeutics for tardive dyskinesia and other neuroleptic-induced movement disorders. Dr. Rotrosen's research group has participated in the development of most of the new novel antipsychotic agents and in the development of LAAM, buprenorphine, and a buprenorphine/naloxone combination for opiate addiction. He is Director of the New York Node of the NIDA Clinical Trials Network and Director of an NIMH/NYU program to train future mental health clinical researchers.

View Presentation - Thursday [PDF format, 124K]
View Presentation - Friday [PDF format, 72K]

<< Back


Bruce J. Rounsaville, M.D.
Director
Connecticut Veterans Affairs Healthcare System
Professor of Psychiatry
New England Mental Illness Research Education and Clinical Center
Yale University School of Medicine
Room 151D
950 Campbell Avenue
West Haven, CT 06516
(203) 937-3486, ext. 7401
(203) 937-3869 Fax
bruce.rounsaville@yale.edu

Dr. Rounsaville received his M.D. degree from the University of Maryland School of Medicine in 1974. Since joining the Yale University faculty in 1977, he has focused his clinical research on the diagnosis and treatment of patients with alcohol and other drug dependence. Using modern methods of psychiatric diagnosis, Dr. Rounsaville was among the first to call attention to the high rates of dual diagnosis in individuals who abuse drugs. As a member of the Work Group to Revise DSM-III, he led the adoption of the drug dependence syndrome concept into the DSM-III-R and DSM-IV substance use disorders criteria. Dr. Rounsaville has been a strong advocate for adopting psychotherapies shown to be effective in rigorous clinical trials. He has played a key role in clinical trials on the efficacy of a number of important treatments, including outpatient clonidine/naltrexone for opioid detoxification, naltrexone for treatment of alcohol dependence, cognitive-behavioral treatment for cocaine dependence, and disulfiram treatment for alcoholic cocaine abusers.

View Presentation [PDF format, 112K]

<< Back


What's New Contents


Blending Conference Bridge Logo

Sponsored by
National Institute on Drug Abuse
National Institutes of Health
Department of Health and Human Services

In partnership with
The New York CTN Node/New York University School of Medicine
The Long Island CTN Node/Columbia University and New York State Psychiatric Institute
New York State Office of Alcoholism and Substance Abuse Services
Alcoholism and Substance Abuse Providers of NYS
Northeast Addiction Technology Transfer Center (ATTC)
New York State Practice Improvement Collaborative (PIC)



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal